NZ598361A - Compositions comprising tramadol and celecoxib in the treatment of pain - Google Patents

Compositions comprising tramadol and celecoxib in the treatment of pain

Info

Publication number
NZ598361A
NZ598361A NZ598361A NZ59836110A NZ598361A NZ 598361 A NZ598361 A NZ 598361A NZ 598361 A NZ598361 A NZ 598361A NZ 59836110 A NZ59836110 A NZ 59836110A NZ 598361 A NZ598361 A NZ 598361A
Authority
NZ
New Zealand
Prior art keywords
pain
tramadol
celecoxib
rac
hci
Prior art date
Application number
NZ598361A
Other languages
English (en)
Inventor
Ces Sebastia Videla
Salido Enrique Portillo
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41566149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ598361(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NZ598361A publication Critical patent/NZ598361A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ598361A 2009-10-16 2010-10-15 Compositions comprising tramadol and celecoxib in the treatment of pain NZ598361A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09384004A EP2311446A1 (en) 2009-10-16 2009-10-16 Compositions comprising Tramadol and Celecoxib in the treatment of pain
PCT/EP2010/006317 WO2011045075A1 (en) 2009-10-16 2010-10-15 Compositions comprising tramadol and celecoxib in the treatment of pain

Publications (1)

Publication Number Publication Date
NZ598361A true NZ598361A (en) 2014-01-31

Family

ID=41566149

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ598361A NZ598361A (en) 2009-10-16 2010-10-15 Compositions comprising tramadol and celecoxib in the treatment of pain

Country Status (33)

Country Link
US (3) US8569271B2 (OSRAM)
EP (3) EP2311446A1 (OSRAM)
JP (2) JP5579858B2 (OSRAM)
KR (1) KR101688996B1 (OSRAM)
CN (2) CN102573824A (OSRAM)
AR (1) AR078653A1 (OSRAM)
AU (1) AU2010306114B2 (OSRAM)
BR (1) BR112012005044B8 (OSRAM)
CA (1) CA2771651C (OSRAM)
CO (1) CO6511249A2 (OSRAM)
CY (1) CY1114960T1 (OSRAM)
DK (1) DK2488170T3 (OSRAM)
EC (1) ECSP12011735A (OSRAM)
ES (1) ES2450615T3 (OSRAM)
HR (1) HRP20140157T1 (OSRAM)
IL (1) IL218096A (OSRAM)
IN (1) IN2012DN01434A (OSRAM)
MA (1) MA33743B1 (OSRAM)
MX (1) MX2012003051A (OSRAM)
MY (1) MY156275A (OSRAM)
NZ (1) NZ598361A (OSRAM)
PL (1) PL2488170T3 (OSRAM)
PT (1) PT2488170E (OSRAM)
RS (1) RS53202B (OSRAM)
RU (2) RU2707752C2 (OSRAM)
SG (1) SG178833A1 (OSRAM)
SI (1) SI2488170T1 (OSRAM)
SM (1) SMT201400035B (OSRAM)
TN (1) TN2012000059A1 (OSRAM)
TW (1) TWI466668B (OSRAM)
UA (1) UA108213C2 (OSRAM)
WO (1) WO2011045075A1 (OSRAM)
ZA (1) ZA201202151B (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2177215A1 (en) 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
US8746719B2 (en) * 2010-08-03 2014-06-10 Polaris Industries Inc. Side-by-side vehicle
ES2836808T3 (es) * 2011-04-05 2021-06-28 Optosolve Res & Development Ltd Tratamientos oftálmicos
CN106421792A (zh) 2012-02-06 2017-02-22 创新医学概念有限责任公司 包含抗病毒成分和cox‑2抑制剂成分组合的药物组合物及用于药物组合疗法的药盒
WO2016116942A1 (en) 2015-01-20 2016-07-28 Anlon Chemical Research Organization Novel pharmaceutical compounds comprising ticagrelor with salts of aspirin
CN117547528A (zh) * 2015-05-28 2024-02-13 瑞迪博士实验室有限公司 用于治疗疼痛的塞来昔布口服组合物
KR101710792B1 (ko) * 2015-07-14 2017-02-28 주식회사 유영제약 세레콕시브 및 트라마돌을 함유하는 약제학적 조성물
MX2016006464A (es) * 2016-05-18 2017-11-17 Laboratorios Liomont S A De C V Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor.
WO2017208069A2 (en) * 2016-05-27 2017-12-07 Dr. Reddy's Laboratories Ltd. Oral composition of celecoxib for treatment of pain
WO2018186650A2 (ko) * 2017-04-03 2018-10-11 주식회사 킴스헬스케어 트라마돌과 셀레콕시브를 포함한 경구투여용 이중 복합정제
KR102033716B1 (ko) * 2017-04-03 2019-10-17 주식회사 킴스헬스케어 트라마돌과 셀레콕시브를 포함한 경구투여용 이중 복합정제
KR102631399B1 (ko) 2018-03-30 2024-02-01 씨지인바이츠 주식회사 폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물
PH12021552785A1 (en) * 2019-05-14 2022-09-05 Esteve Pharmaceuticals Sa Use of co-crystals of tramadol and celecoxib for treating pain while reducing the abuse liability of tramadol
CN112007024A (zh) * 2019-05-28 2020-12-01 江苏恒瑞医药股份有限公司 艾瑞昔布与曲马多联合在制备治疗疼痛的药物中的用途
EP4267132A1 (en) 2020-12-28 2023-11-01 Dr. Reddy's Laboratories Ltd. Celecoxib for treating pain
WO2025125888A1 (en) * 2023-12-15 2025-06-19 Centro De Investigación Y De Estudios Avanzados Del I.P.N. Aripiprazole and tramadol compositions with potentiation effects and high analgesic efficacy useful for the treatment of neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661723B2 (en) 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5516803A (en) 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
JP2002538176A (ja) * 1999-03-01 2002-11-12 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド トラマドール物質および選択的ｃｏｘ−２阻害薬を含んで成る組成物
DE19927688A1 (de) 1999-06-17 2000-12-21 Gruenenthal Gmbh Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
ES2376500T3 (es) * 2002-02-19 2012-03-14 Adcock Ingram Limited Combinaciones farmacéuticas de meloxicam, tramadol y paracetamol.
US20080031950A1 (en) * 2007-04-27 2008-02-07 Nectid Inc. Novel anelgesic combination
BR112012005011B8 (pt) 2009-10-16 2021-05-25 Esteve Pharmaceuticals Sa cocristal de tramadol e celecoxib, processo para sua produção e composição farmacêutica
EP2392319A1 (en) 2010-06-04 2011-12-07 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compositions of co-crystals of tramadol and coxibs

Also Published As

Publication number Publication date
TW201114418A (en) 2011-05-01
PL2488170T3 (pl) 2014-05-30
ES2450615T3 (es) 2014-03-25
AU2010306114B2 (en) 2015-07-23
CN107050006A (zh) 2017-08-18
MX2012003051A (es) 2012-05-29
BR112012005044B8 (pt) 2021-05-25
RU2016125895A3 (OSRAM) 2018-12-05
HK1173379A1 (en) 2013-05-16
AU2010306114A1 (en) 2012-03-15
CO6511249A2 (es) 2012-08-31
ECSP12011735A (es) 2012-05-30
MA33743B1 (fr) 2012-11-01
IL218096A (en) 2015-02-26
BR112012005044B1 (pt) 2020-12-15
CY1114960T1 (el) 2016-12-14
IL218096A0 (en) 2012-04-30
CA2771651C (en) 2016-08-23
TN2012000059A1 (en) 2013-09-19
SI2488170T1 (sl) 2014-04-30
RS53202B (sr) 2014-06-30
US20150150889A1 (en) 2015-06-04
RU2707752C2 (ru) 2019-11-29
EP2488170B1 (en) 2014-01-22
US20120172341A1 (en) 2012-07-05
SG178833A1 (en) 2012-05-30
US8569271B2 (en) 2013-10-29
DK2488170T3 (en) 2014-03-03
KR101688996B1 (ko) 2016-12-22
TWI466668B (zh) 2015-01-01
SMT201400035B (it) 2014-05-07
JP2013507408A (ja) 2013-03-04
AR078653A1 (es) 2011-11-23
RU2016125895A (ru) 2018-12-05
RU2012120087A (ru) 2013-11-27
BR112012005044A2 (pt) 2016-05-03
KR20120089287A (ko) 2012-08-09
CN102573824A (zh) 2012-07-11
WO2011045075A1 (en) 2011-04-21
US20140024622A1 (en) 2014-01-23
HRP20140157T1 (hr) 2014-03-28
UA108213C2 (uk) 2015-04-10
ZA201202151B (en) 2012-11-28
EP2488170A1 (en) 2012-08-22
EP2311446A1 (en) 2011-04-20
JP2014221797A (ja) 2014-11-27
CA2771651A1 (en) 2011-04-11
PT2488170E (pt) 2014-03-11
IN2012DN01434A (OSRAM) 2015-06-05
EP2737898A1 (en) 2014-06-04
JP5579858B2 (ja) 2014-08-27
MY156275A (en) 2016-01-29

Similar Documents

Publication Publication Date Title
NZ598361A (en) Compositions comprising tramadol and celecoxib in the treatment of pain
MX2011009796A (es) Inhibidores de la cinasa pi3.
WO2009155121A3 (en) Inhibitors of pi3 kinase
WO2007149512A3 (en) Peptide epoxyketones for pr0teas0me inhibition
EP2536736A4 (en) PREPARATION OF 6'-O-SIALYLLACTOSE AND INTERMEDIATE PRODUCTS THEREOF
WO2008033455A3 (en) Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
TW200833663A (en) Therapeutic agents
MX2010006799A (es) Benzofuropirimidinonas como inhibidores de la proteina cinasa.
WO2010017545A3 (en) Triazole compounds that modulate hsp90 activity
MX2008013212A (es) 4-anilinquinolina-3-carboxamidas como inhibidores de la cinsa csf-1r.
PH12014502775A1 (en) TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS
MA32901B1 (fr) Composes utiles pour l'inhibition de la chk1
TNSN08444A1 (en) Bicyclic derivatives as cetp inhibitors
BR112013031262A2 (pt) "exotoxinas a de pseudomonas com menos epítopos imunogênicos de célula b e t, e seu uso no tratamento e prevenção de câncer, bem como molécula quimérica, ácido nucleico, vetor de expressão, células, composição farmacêutica e métodos para inibir crescimento de célula-alvo e de produção de endotoxinas a de pseudomonas e de molécula quimérica".
NZ608116A (en) Triazine-oxadiazoles
MX2011012122A (es) Derivados de tiofeno.
WO2012149186A3 (en) Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
UA99308C2 (ru) Аналог азацитидина и его применение
MX2012006206A (es) Preparaciones combinacion comprendiendo exosomas y corticosteroide.
WO2008034142A3 (en) Synthesis, methods of using, and compositions of cycloalkylmethylamines
CA2767833C (en) N-acetyl cysteine compositions and methods to improve the therapeutic efficacy of acetaminophen
WO2010062038A3 (ko) 티로신 키나아제 저해 화합물, 이의 이성질체 또는 이의 약학적으로 허용가능한 염 및 이를 포함하는 약학적 조성물
NZ598353A (en) Co-crystals of tramadol and coxibs
ZA200810031B (en) 1,3-disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their use for the manufacture of medicaments
NZ593438A (en) Synthesis of polymer conjugates of indolocarbazole compounds

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 15 OCT 2017 BY PAVIS EG

Effective date: 20140904

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 OCT 2018 BY DENNEMEYER + CO

Effective date: 20170927

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 OCT 2019 BY DENNEMEYER + CO

Effective date: 20180928

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 OCT 2020 BY PAVIS GMBH

Effective date: 20190924

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 OCT 2021 BY THOMSON REUTERS

Effective date: 20200926

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 OCT 2022 BY THOMSON REUTERS

Effective date: 20210902

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 OCT 2023 BY THOMSON REUTERS

Effective date: 20220902

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 OCT 2024 BY THOMSON REUTERS

Effective date: 20230904

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 OCT 2025 BY THOMSON REUTERS

Effective date: 20240903

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 OCT 2026 BY THOMSON REUTERS

Effective date: 20250901